Dialysis world news


Dialysis Patient Citizens Announces New President of the Board of Directors - Sacramento Bee

WASHINGTON, May 24, 2012 -- /PRNewswire-USNewswire/ -- Dialysis Patient Citizens (DPC) is proud to announce Eric Edwards has been named President of the DPC Board of Directors.  Edwards, a longtime advocate for kidney disease patients, has been a DPC Board Member since 2010.

"I am honored and excited to take on this new opportunity.  I have always felt my purpose on Earth has been to inform and empower ESRD patients and their families, because when you know better, you do better," said Eric Edwards.  "I look forward to working with the Board of Directors and DPC's patient membership to further our mission of improving the quality of life for all dialysis patients."

Eric Edwards was diagnosed with Nephritis at an early age and began his journey as an ESRD patient at age nineteen.  He received his first kidney transplant in 1999 and returned to hemodialysis six years later when the transplant failed.  Eric joined the Board of Directors in 2010 and previously served as a DPC Patient Ambassador for several years.  He holds a dual B.B.A. in Finance and Marketing from J. Mack Robinson College of Business at Georgia State University and lives in Atlanta, GA.

Eric Edwards succeeds former President Nancy Scott, who served as President from April 2011.  Her term ended prematurely after she received a kidney transplant last spring, as the DPC by-laws require the Board President be a current dialysis patient.  Scott will continue to serve on the Board of Directors and as the Chair of the Education Committee.

"Nancy Scott has been a relentless advocate for her fellow kidney patients around the country and her contributions to our organization during her short tenure as President have been innumerable,"said Hrant Jamgochian, DPC Executive Director.  "While she will no longer serve as Board President, we are excited about her dedication to our mission and her continued involvement with our organization."

About Dialysis Patient Citizens: Dialysis Patient Citizens is a nationwide, non-profit, patient-led organization working to improve the quality of life for all dialysis patients through education and advocacy. The Board of Directors is comprised solely of end stage renal disease (ESRD) patients who guide the policies and mission of the organization. You can find more information atwww.dialysispatients.org.

Press Contact: Jessica Nagro 202-789-6931

SOURCE Dialysis Patient Citizens

...

 
Improved Quality of Life with More Frequent HHD - Renal Business Today

LAWRENCE, Mass.—NxStage Medical, Inc., today announced the latest interim findings from its FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements) Study, which found daily home hemodialysis (HHD) treatments with the NxStage System One are associated with long-term improvements in various physical and mental quality of life measures.

These interim FREEDOM Study results, "At-Home Short Daily Hemodialysis Improves the Long-Term Health-Related Quality of Life," were published online on Kidney International's website in advance of its release in print.

NxStage's FREEDOM Study is the largest prospective study of frequent HHD to date. The FREEDOM Study reported improvements in several quality of life measures in end stage renal disease (ESRD) patients at 12 months of follow-up, including:

...

 
Infections May Be Deadly for Many Dialysis Patients - Newswise (press release)
image

10% to 20% of dialysis patients receive peritoneal dialysis.

Newswise — Washington, DC (May 24, 2012) — An infection called peritonitis commonly arises in the weeks before many dialysis patients die, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings suggest that peritonitis may be a deadly condition for some kidney failure patients.

Most kidney failure patients on dialysis get their treatments at a clinic, through hemodialysis. But about 10% to 20% receive treatments at home through peritoneal dialysis, where fluids are first pumped into the abdominal cavity to collect wastes from the blood and are later removed from the body. Unfortunately this fluid can become infected, causing a condition called peritonitis. This occurs as commonly as twice a year to once every five or six years.

Neil Boudville (University of Western Australia, in Perth) and his colleagues evaluated whether peritonitis affects the survival of patients on peritoneal dialysis. They looked at information from all kidney failure patients (1,316 individuals) who received dialysis in Australia and New Zealand from May 2004 through December 2009 and who died while undergoing treatment or soon after.

Compared with the rest of the year, patients were more likely to develop peritonitis during the 120 days prior to their death, and even more so during the final month before their death. Specifically, they were six times as likely to develop peritonitis during the 30 days prior to their death compared with six months earlier.

“We have therefore proposed a potential new definition for a cause of death—“peritonitis-associated death”—being any death within 30 days of an episode of peritonitis,” said Prof Boudville.

Study co-authors include Anna Kemp, PhD, Philip Clayton, Wai Lim, PhD, Sunil Badve, Carmel Hawley, Stephen McDonald PhD, Kathryn Wiggins, MD, Kym Bannister, MD, Fiona Brown PhD.

Disclosures: Neil Boudville has previously received research funds from Roche, travel grants from Roche, Amgen and Jansen Cilag, and speaking honoraria from Roche. Wai Lim is on the Advisory Board for Novartis, Genzyme, Bristol Myer Squibb and Pfizer, he has also received research grants from Novartis, Genzyme and Pfizer, plus speaking honoraria from Novartis and Genzyme. David Johnson is a consultant for Baxter Healthcare Pty Ltd and Fresenius Medical Care and has previously received research funds from Baxter. He has also received speakers’ honoraria and research grants from Fresenius Medical Care and Baxter. Kym Bannister is a consultant for Baxter Healthcare Pty Ltd, on their Clinical Advisory Board and received speaking honoraria. Fiona Brown is a consultant for Baxter and Fresenius and has received travel grants from Amgen and Roche. Stephen McDonald has received speaking honoraria from AMGEN Australia, Fresenius Australia and Solvay Pharmaceuticals and travel grants from AMGEN Australia, Genzyme Australia and Jansen-Cilag. The remaining authors have no competing financial interests to declare.

The article, entitled “Recent Peritonitis Associates with Mortality Among Patients Treated with Peritoneal Dialysis,” will appear online at http://jasn.asnjournals.org/ on May 24, 2012, doi: 10.1681/ASN.2011121135.

The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.

Founded in 1966, and with more than 13,500 members, the American Society of Nephrology (ASN) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality care for patients.

# # #


Comment/Share


...

 
Obese Patients Face Increased Risk of Kidney Damage After Heart Surgery - Newswise (press release)
image

Acute kidney injury affects 5% to 30% of heart surgery patients.

Newswise — Washington, DC (May 24, 2012) — Oxidative stress may put obese patients at increased risk of developing kidney damage after heart surgery, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). Effective antioxidants or other therapies that reduce oxidative stress might help lower this risk, particularly among obese patients.

Acute kidney injury (AKI), an abrupt decline in kidney function, is an increasingly prevalent and potentially serious condition following major surgery. Sometimes AKI arises after heart surgery because the kidneys are deprived of normal blood flow during the procedure.

To see if extra body weight puts patients at increased risk for developing AKI following heart surgery, Frederic Billings IV, MD (Vanderbilt University School of Medicine) and his colleagues evaluated information from 445 heart surgery patients, 112 of whom (25%) developed AKI.

Among the major findings:
• Obese patients (body mass index, or BMI, ?30 kg/m2) had an increased risk of developing AKI; specifically, a 26.5% increased risk per 5 kg/m2 increase in BMI.
• Oxidative stress, which generates harmful unstable reactive oxygen molecules, plays a role in the link between obesity and AKI.

“The identification of oxidative stress during surgery as a possible mechanism for the development of kidney injury following surgery provides an opportunity to develop and test therapeutic treatments for surgical patients,” said Dr. Billings.
Study co-authors include Mias Pretorius, MD, Jonathan Schildcrout, PhD, Nathaniel Mercaldo, John Byrne, MD, T. Alp Ikizler, MD, Nancy J. Brown, MD (Vanderbilt University School of Medicine).

Disclosures: The authors reported no financial disclosures.

The article, entitled “Obesity and Oxidative Stress Predict Acute Kidney Injury Following Cardiac Surgery,” will appear online at http://jasn.asnjournals.org/ on May 24, 2012, doi: 10.1681/ASN.2011090940.

The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.

Founded in 1966, and with more than 13,500 members, the American Society of Nephrology (ASN) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality care for patients.

# # #


Comment/Share


...

 
Infections may be deadly for many dialysis patients - EurekAlert (press release)
EurekAlert (press release)
An infection called peritonitis commonly arises in the weeks before many patients on peritoneal dialysis die. More studies are needed to determine whether peritonitis causes premature death in dialysis patients. Washington, DC (May 24,

...

 
<< Start < Prev 351 352 353 354 355 356 357 358 359 360 Next > End >>

Page 359 of 2630
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.